Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

New Database for Sharing MS Clinical Trial Data

April 25, 2016 11:28 am | by The Critical Path Institute (C-Path) | News | Comments

A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators. 


House Tries to Sort Out Legislative Response to Drug Abuse

April 25, 2016 11:00 am | by Mary Clare Jalonick, Associated Press | News | Comments

Heroin and opioid painkiller abuse is a growing, deadly problem that has become a top political issue in many states.


Successful Lab Test of Photoswitchable Anti-Tumor Agent

April 25, 2016 8:40 am | by Karlsruher Institut Fur Technologie (KIT) | News | Comments

Photodynamic therapy (PDT) in medicine usually uses a substance that reacts to light and converts the oxygen in the tissue into aggressive radicals. 


Can We Hypercharge Vaccines?

April 25, 2016 8:24 am | by Boston Children's Hospital | News | Comments

The findings could enhance vaccines and make them much more effective.


First Gene Therapy Successful Against Human Aging

April 25, 2016 8:23 am | News | Comments

The treatment was originally intended to demonstrate the safety of the latest generation of the therapies.


Doubling Down on Dengue

April 25, 2016 8:22 am | by Harvard Medical School | News | Comments

Harvard Medical School scientists have found a compound that in laboratory dishes blocks the dengue virus in two ways.


The Rise and Fall of Theranos

April 25, 2016 8:21 am | by Norman A. Paradis, Dartmouth College, The Conversation | News | Comments

How has this widely acclaimed biomedical innovator fallen so far, so fast?


Increasing Cases of Anaphylaxis Among Children

April 25, 2016 8:00 am | by McGill University Health Centre | News | Comments

It is estimated that almost 600,000 Canadians will experience anaphylaxis in their lifetime and that more than half of the individuals who had anaphylaxis were not equipped with life-saving epinephrine.


Molecule-Building Method Opens Vast Realm of Chemistry for Pharma

April 25, 2016 7:30 am | by The Scripps Research Institute | News | Comments

Chemists have long dreamed of using similarly cheap and easy techniques to make carbon-to-carbon couplings.


Virginia to Shield Identities of Execution Drug Suppliers

April 24, 2016 11:15 am | by Alanna Durkin Richer, Associated Press | News | Comments

Lawmakers in states across the country have considered or adopted secrecy laws to help ensure a steady supply of lethal injection drugs.


AstraZeneca Taps Gene Pioneer Venter for Huge Drug-Hunting Sweep

April 23, 2016 10:30 am | by Ben Hirschler, Reuters | News | Comments

The initiative, announced on Friday, involves sequencing up to 2 million human genomes.


Report: Valeant Finalizing Contract With Perrigo's CEO

April 22, 2016 3:00 pm | by The Associated Press | News | Comments

Perrigo said Friday that it would not comment on "speculation or market rumor."


UF Health Researchers Develop Unique Model for Studying ALS

April 22, 2016 2:00 pm | by University of Florida | News | Comments

The new mouse model is significant because it closely replicates the symptoms and gene expression patterns found in people who have the most common genetic cause of ALS. 


Researchers Uncover 'Local Heroes' of Immune System

April 22, 2016 12:44 pm | by Walter + Eliza Hall Institute | News | Comments

Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion'.


UN Hears Major Differences on Global Approach to Drug Abuse

April 22, 2016 11:15 am | by Edith M. Lederer, Associated Press | News | Comments

The first U.N. General Assembly special session to address global drug policy in nearly 20 years heard major differences on the approach to drug use on its second day on Wednesday.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.